Flares of acute graft-versus-host disease (GVHD) : : a mount sinai acute gvhd international consortium (MAGIC) analysis
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Ausgabe
-
Online first
- Sprache
-
Englisch
- Anmerkungen
-
Blood advances. - (2024) , ISSN: 2473-9537
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2024
- Urheber
- DOI
-
10.1182/bloodadvances.2023012091
- URN
-
urn:nbn:de:bsz:25-freidok-2467248
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akahoshi, Yu
- Zeiser, Robert
- Ferrara, James L. M.
- Levine, John E.
- Nakamura, Ryotaro
- Universität
Entstanden
- 2024
Ähnliche Objekte (12)
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
GVHD, IBD, and primary immunodeficiencies: The gut as a target of immunopathology resulting from impaired immunity
The MAGIC algorithm probability predicts treatment response and long-term outcomes to second-line therapy for acute GVHD
Intestinal microbiota influence immune tolerance post allogeneic hematopoietic cell transplantation and intestinal GVHD
Editorial on translational research in graft-versus-host disease (GVHD) and graft-versus-tumor (GVT) effect after allogeneic hematopoietic cell transplantation
Kinase inhibition as treatment for acute and chronic graft-versus-host disease
The role of purine metabolites as DAMPs in acute graft-versus-host disease
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Therapy response of glucocorticoid-refractory acute GVHD of the lower intestinal tract
Acute graft-versus-host disease, infections, vascular events and drug toxicities affecting the central nervous system
Advances in understanding the pathogenesis of graft‐versus‐host disease
Deciphering the role of the major histocompatibility complex, the intestinal microbiome and metabolites in the pathogenesis of acute graft-versus-host disease
Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape